Camrelizumab Combined With Apatinib for Recurrent Resistant GTN

Clinical trial NCT04047017 · COMPLETED

Trial details

NCT number: NCT04047017
Sponsor: Peking Union Medical College Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Gestational Trophoblastic Disease

Start date: 2019-08-08
Primary completion: 2021-03-18
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.